<Blinded Review: TIME_ANON_0478>
**Composite Score:** 4.3 / 10.0 (Rigor: 1.4/3.5 | Claims: 1.1/2.5 | Biology: 0.9/2.0 | Reproducibility: 0.9/2.0)
**Scientific Core Score:** 3.4 / 8.0
**Bias Category:** Statistical/Design
**Verdict:** Major Revision
**Study Modality:** Wet-Lab Primary Experimental
**Technology Maturity:** Commodity/Hype-Cycle Template
**Epistemic Stage:** Clinical/Observational

OVERALL_SCORE: 4.3/10
VERDICT: CAVEATS
ESTIMATED_DECADE: 2020s

---

### 1. Executive Summary / SUMMARY
This five-center hospital-based case–control candidate-gene study genotypes three SNPs (`rs1048147 C>A`, `rs6494 T>A`, and `rs176942 A>G`) in the *ALKBH1* gene using TaqMan assays in 414 Chinese Han children with Wilms tumour (398 successfully genotyped) and 1,199 healthy controls (1,198 genotyped). Using unconditional logistic regression adjusted for age and sex, the authors report a nominal protective association for `rs6494 T>A` (`TA` vs. `TT`: adjusted $\text{OR} = 0.59$, $95\%\text{ CI} = 0.39\text{–}0.87$, $p = 0.009$; dominant `TA/AA` vs. `TT`: $\text{AOR} = 0.61$, $p = 0.014$), construct a combined "protective genotype" count across all three SNPs, perform 8-haplotype and 10-stratum subgroup analyses, and query public GTEx whole-blood and fibroblast eQTL summary statistics. While the multi-center pediatric case–control cohort is sizable for a rare embryonal tumor, the study follows a formulaic candidate-SNP template (re-analysing the same cohort previously tested for *TRMT6*, *FTO*, *YTHDC1*, and *YTHDF2* SNPs in refs. [20–23, 31–32]) and suffers from uncalibrated multiple hypothesis testing, circular post-hoc definition of "protective genotypes" from null SNPs, lack of population stratification controls across five geographically distinct Chinese cities, and a glaring self-contradiction in the Discussion regarding whether `rs6494` is a 3'-UTR miRNA-binding variant or a coding Met-to-Leu missense mutation.

### 2. Methodological & Statistical Audit / STRENGTHS / WEAKNESSES & METHODOLOGICAL AUDIT

#### STRENGTHS
- Multi-center pediatric cohort of 398 genotyped Wilms tumour cases and 1,198 age- and sex-matched controls with Hardy–Weinberg equilibrium verified in controls ($p > 0.11$ for all three SNPs) and 10% plate-level genotyping replicates.

#### WEAKNESSES & METHODOLOGICAL AUDIT
- **Direct Self-Contradiction on the Molecular Identity of `rs6494`:** In the Discussion (line 138), the authors state: *"Located in the 3'UTR of ALKBH1, rs6494 T>A may affect microRNA binding, leading to the downregulation of ALKBH1..."* Immediately in the next paragraph (line 140), they write: *"The rs6494 is located in the coding region of the ALKBH1 gene and results in a mutation from the T allele to the A allele, resulting in an amino acid substitution from methionine (Met, M) to leucine (Leu, L)."* These two statements are mutually exclusive and indicate unverified assembly of bioinformatic annotations.
- **Post-Hoc Circularity in "Combined Protective Genotypes" Analysis:** Neither `rs1048147` (dominant $p = 0.232$) nor `rs176942` (dominant $p = 0.639$) is statistically significant. Nevertheless, the authors state (line 60): *"although not significant, a tendency toward a protective effect was observed for rs1048147 C>A and rs176942 A>G. We then defined rs1048147 CA/AA, rs6494 TA/AA and rs176942 AG/GG as protective genotypes on the basis of their ORs."* Selecting allele directions post-hoc based on in-sample ORs $< 1$ and then computing a composite $p$-value ($p = 0.009$, Table 1) on the exact same dataset violates basic statistical independence and inflates Type I error.
- **No Multiple-Testing Correction Across SNPs, Models, Haplotypes, Stratifications, and Prior Cohort Publications:** The manuscript performs over 40 hypothesis tests (3 SNPs $\times$ 4 inheritance models + combined score in Table 1; 7 haplotypes in Table 2; 10 clinical/demographic subgroups $\times$ 2 models in Table 3) at an unadjusted threshold of $p < 0.05$, on top of testing multiple other m1A-regulator genes (*TRMT6*, *FTO*, *YTHDC1*, *YTHDF2*) in the exact same case–control cohort. Under a Bonferroni correction for even the 30 tests within Tables 1–3 ($\alpha \approx 0.0017$), the primary association (`rs6494` dominant $p = 0.014$, additive $p = 0.028$), the `AAA` haplotype ($p = 0.027$, based on only 8 case alleles), and all subgroup interactions fail to reach significance.
- **Non-Monotonic Homozygote Effect for `rs6494`:** In Table 1, the `TA` heterozygote has $\text{AOR} = 0.59$ ($32/398$ cases vs. $157/1198$ controls), whereas the `AA` homozygote trends in the opposite direction ($\text{AOR} = 2.91$, $2/398$ cases vs. $2/1198$ controls), driven by a low minor allele frequency ($\text{MAF} \approx 6.7\%$ in controls).
- **Inappropriate Haplotype Inference Across Unlinked SNPs and Unmatched Subgroup Controls:** In Methods (line 45), the authors state there is no LD among the three SNPs ($R^2 = 0.015$, $0.008$, and $0.095$), yet they perform phasing and haplotype association testing in Table 2 without reporting the phasing algorithm or accounting for phase uncertainty. Furthermore, in Table 3 (lines 119–124), each clinical stage subgroup (e.g., Stage III with 90 cases) is compared against the entire unstratified pool of 1,198 controls despite the controls having been age- and sex-matched to the overall case cohort, without adjusting for enrollment center.
- **Mismatch Between GTEx Tissues and Embryonal Renal Tumorigenesis:** The eQTL lookups in Figure 1 rely entirely on adult GTEx whole blood and cultured fibroblasts rather than developing kidney or nephroblastoma tissue.

### 3. Biological / Experimental Grounding & Claim Proportionality
- **Claim 1: `rs6494 T>A` is a statistically validated Wilms tumour susceptibility locus.** `[Overstated]` — The nominal association ($p = 0.014$ dominant, $p = 0.028$ additive) does not survive multiple-testing correction across the study's test matrix and lacks an independent replication cohort.
- **Claim 2: Synergistic/cumulative protective effects of *ALKBH1* SNPs and haplotypes.** `[Methodologically Flawed]` — Derived from circular post-hoc pooling of two null SNPs (`rs1048147` and `rs176942`) with `rs6494`.
- **Claim 3: Mechanistic link via 3'-UTR miRNA binding vs. coding Met-to-Leu substitution.** `[Methodologically Flawed]` — Contradicts itself across consecutive paragraphs in the Discussion and lacks any experimental validation in renal cells.

### 4. Reproducibility & Data Completeness
- TaqMan assay IDs / probe sequences and center-specific sample counts are not provided in the main text (Table S1 is referenced as supporting information).
- Individual-level genotypes are not deposited in a public repository.
</Blinded Review: TIME_ANON_0478>
